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Abstract
Background, aim, and scope This review deals with
publications concerning the mode of action of Bt proteins
and their potential synergism with extrinsic factors. The
aim was to assess the impact of those factors especially
regarding selectivity and efficacy of Bt toxins and to
discuss possible gaps in current risk assessment of
genetically engineered plants expressing Bt toxins.
Main features The review shows that several extrinsic
factors are able to influence the selectivity and efficacy of
Bt toxins. The findings are seen as being relevant for risk
assessment in Bt plants. This conclusion is derived by
discussing current state of knowledge about the mode of
action of Bt proteins, unexpected effects on non-target
organism, and the way how modified Bt toxins are
expressed in genetically engineered plants.
Results Several publications have been identified that show
that certain factors and synergism can impact efficacy and
selectivity of Bt toxins. These extrinsic factors are various
and include other Bt toxins or parts from the spore of
Bacillus thuringiensis as well as certain enzymes, environ-
mental stress, non-pathogenic microorganisms, and infec-
tious diseases.
Discussion Research on the underlying mechanism of
observed synergism might help to explain some of the
effects found in non-target organisms. In general, possible
synergism of Bt toxins with extrinsic factors can be relevant
for risk assessment of genetically engineered Bt plants since
they expose a modified Bt toxin to the environment under
various conditions and over a long period of time.
Conclusions Risk assessment of genetically engineered
plants should put into question the general assumption of
a high selectivity and a linear dose–response relationship in
the toxicity of Bt proteins. Both selectivity and efficacy can
be influenced by synergism, which can provoke unexpected
and undesired effects in non-target organisms.
Perspectives It is suggested that systematic research be
promoted on synergism between Bt toxins and potential
extrinsic factors that could impact the spectrum of
susceptible organisms. This research should become a




1 Background, aim, and scope
So-called Bt plants are one of the dominant genetically
engineered crops grown on a large scale and in many
regions of the world (ISAAA 2009). There is a wide range
of issues being discussed in the context of the risk
assessment of these Bt plants. This review deals with
specific aspects of risk assessment of the insecticidal Bt
toxins, which are produced in the genetically engineered
plants. It is important to understand its mode of action and
possible interference with elements from its environment, to
be sure that the Bt plants and their toxins do not show
unexpected or even hazardous effects under changing
environmental conditions. This is especially relevant since
Bt Plants are being grown under various regional and
climatic conditions; the Bt toxins are produced throughout
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e-mail: christoph.then@scouting-biotech.dethe growing season and get in contact with the environment
above and below the ground as well as being used in feed
and food. This issue was elaborated by a review of the
current literature; in addition, a questionnaire was devel-
oped for consulting experts to improve the coverage. To
identify contributions that might be difficult to access
otherwise, it was agreed (with the experts) to keep their
input anonymous.
One crucial issue identified is that published scien-
tific literature not only shows some open questions
concerning the general mode of action of Bt toxins
(Gilliland et al. 2002;C r i c k m o r e2005;H i l b e c ka n d
Schmidt 2006) but also gives some indications that the
toxicity of Bt toxins is influenced by several factors. On
the one hand, it is known that, in general, the toxicity of
Bt toxins in target organisms depends on factors such as
certain pH, proteases, and receptors (Oppert 1999;d e
Maagd et al. 2001). On the other hand and more
specifically, extrinsic factors and specific cofactors can
also influence the efficacy of Bt toxins in resistant target
organisms and/or might also impact on selectivity and
toxicity in non-target organisms (see for example Schnepf
et al. 1998;S h a r m ae ta l .2004). While the issue of
efficacy of Bt toxins in resistant target organisms is also of
economical relevance and quite well investigated by
several authors, the potential change of toxicity for non-
target organisms so far is hardly reflected in literature. The
aim of this review was to identify publications dealing
with relevant factors and their synergisms with Bt toxins
and to discuss their specific relevance for risk assessment
in genetically engineered plants.
2 Main features
Published literature shows that a broad range of extrinsic
factors are able to influence the selectivity and/or efficacy
of Bt toxins. Some authors even see factors such as gut
bacteria as a necessary precondition for toxicity in target
organisms (Broderick et al. 2006). Several publications deal
with the question how synergism or technological mod-
ifications can be used to overcome emergent resistance or
make Bt toxins more efficient with target organisms
(Dubois and Dean 1995; Lee et al. 1996; Liu et al. 1998;
Soberon et al. 2007). These publications should lead to a
discussion of whether some factors also can influence
resistance to Bt toxins in non-target organisms. It is
interesting that, for example, the Cry1Ab protein produced
in genetically engineered plants is already modified in a
way that could influence its selectivity, being partially
processed and activated by plant enzymes (Li et al. 2007).
This modification of the protein, caused by technical
processing of the DNA (Hilbeck and Schmidt 2006) and
additionally influenced by plant enzymes acting as
cofactors (Li et al. 2007), might help to explain some
unexpected effects seen in non-target organisms (Schmidt
et al. 2008; Hilbeck et al. 1998;B ø h ne ta l .2008;R o s i -
Marshall et al. 2007; Ramirez-Romero et al. 2008). For
example, Thomas and Ellar (1983) show that solubilizing
of certain Bt proteins (derived from Bacillus thuringiensis
var israelensis) can change their toxicity on mammals.
Besides enzymatic processing, there are several other
factors that can influence the toxicity and selectivity of Bt
proteins, such as a combination of biotic and abiotic stress
factors (Koppenhöfer and Kaya 1997; Kramarz et al.
2007), infectious diseases (Dubois and Dean 1995),
normal gut bacteria (Broderick et al. 2006 and 2009),
interactivity with other Bt toxins and/or the spore part of
t h et o x i n s( L e ee ta l .1996;L i ue ta l .1998; Perez et al.
2005;S c h n e p fe ta l .1998;S h a r m ae ta l .2004). These
findings make evident the relevance of these effects for
ecological risk assessment of Bt crops. In this context, it
also should be reflected that the current theory, which
explains toxicity of Bt toxins such as Cry1Ab in target
organisms (de Maagd et al. 2001), leaves room for several
open questions (Crickmore 2005; Gilliland et al. 2002)
and even contradicting explanations (Zhang et al. 2005,
2006; Broderick et al. 2006; Soberon et al. 2007). In
general, it seems premature to rely on the assumed
selectivity and a linear dose–response relationship as
suggested by Monsanto (2007). On the contrary, the issue
of synergism, efficacy, and selectivity remains a gap in
current risk assessment.
3 Results
B. thuringiensis belongs to the Bacillus cereus group,
which contains Bacillus cereus, B. thuringiensis, Bacillus
anthracis, Bacillus mycoides, and others (Pigott and Ellar
2007). Toxins of the Cry classification belong to a group of
extremely potent toxins that can provoke lesions in the cell
membrane; the resulting cell death can be caused by several
mechanisms (Tilley and Saibil 2006). Risk assessment of Bt
crops is largely based on the evidence that, in target
organisms, specific receptors are needed to enable the
toxicity of Bt toxins (see for example Schnepf et al. 1998;
de Maagd et al. 2001; Monsanto 2007). These specific
receptors observed in target organisms are seen as reason to
expect toxicity of Bt toxins only in specific group of
species. However, apparently, some quite important gaps in
understanding the general mode of action of Bt toxins are
still existing. There are several theories explaining the
mode of action of Bt toxins in target organisms, some of
them contradictory to one another, for example, Zhang et al.
(2005) and Soberon et al. (2007). For Cry1Ab, Zhang et al.
792 Environ Sci Pollut Res (2010) 17:791–797(2005) consider a cascade in metabolism being respon-
sible for the toxicity of the Cry1Ab, with the cadherin
receptor being important just for binding the protein and
starting the cascade. Soberon et al. (2007)o b j e c tt ot h e s e
findings and explain that the cadherin receptor alone is
sufficient to allow the toxins to exert their cytocidal
activity of Cry1Ab. Broderick et al. (2006)m i g h tc o m p l y
with the findings of Soberon et al. (2007) but suggests
that, in any case, additional bacterial activity is necessary
to accomplish the mission of the Cry1Ab toxin. Jimenez-
Juarez et al. (2007) are discussing different explanatory
models and conclude: “Although Bt Cry toxins are widely
used as insecticides their mode of action is still not
completely understood.”
There are several contradictions between the models as
currently discussed, but they all reaffirm the assumption
that specific receptors are needed for the Bt toxins to show
its effects. Pigott and Ellar (2007) are comparing different
models used for explaining the mode of action of Cry
toxins and identify six different types of receptors that can
play a role in activation of the toxins. However, even this
very critical element—the need for a specific receptor—is
still disputed to some extent. For example, Gilliland et al.
(2002) work with several Cry1 toxins and find no
correlation between its binding capacity and its potency
(toxicity), saying “The correlation between binding and
potency was inconsistent for the species-instar-toxin com-
binations used in this study, reaffirming the complex mode
of action of Cry1 toxins.” According to Pigott and Ellar
(2007), most steps of toxin activation are still under
discussion: “Even the general view that toxin monomers
bind to midgut-receptors, oligomerize, and insert into the
membrane to form lytic pores has recently been chal-
lenged.” And Crickmore (2005)w r i t e s :“Nonetheless,
convincing evidence now exists for the involvement of
two proteins (cadherin and aminopeptidase N) and a set of
glycolipids as receptors of Bt toxins. Circumstantial
evidence, based on binding studies, also exists for the
involvement of many other membrane proteins. With so
many potential binding sites, the question arises as to their
relative importance.”
The publications of Broderick et al. (2006, 2009) in
particular reveal surprising results on the general mode of
actions of Bt toxins. By showing that, in gipsy moth
(Lymantria dispar), midgut bacteria are required to induce
insecticidal activity in Cry1Ab toxins (Broderick et al.
2006), the authors believe to describe a new general
mechanism in activity of Bt toxins. As they point out:
“For decades, the mechanism of insect killing has been
assumed to be toxin-mediated lysis of the gut epithelial
cells, which leads to starvation, or B.thuringiensis septi-
cemia. Here, we report that B. thuringiensis does not kill
larvae of the gypsy moth in the absence of indigenous
midgut bacteria. Elimination of the gut microbial commu-
nity by oral administration of antibiotics abolished B.
thuringiensis insecticidal activity, and reestablishment of
an Enterobacter sp. That normally resides in the midgut
microbial community restored B.thuringiensis-mediated
killing.” In a later publication (Broderick et al. 2009),
the published findings were more specific, based on
comparison of six Lepidoptera species subjected to a
treatment combining the application of antibiotics, Bt
toxins, and certain gut bacteria. In most of the Lepidoptera
species, the absence of gut bacteria led to a decrease of
toxicity of the Bt toxins, while in one case, the opposite
effect was observed. Boderick et al. (2009) also identified
certain non-pathogenic gut bacteria from L. dispar being
able to restore toxicity of Bt toxins if they are applied to
insect larvae. They conclude that “perturbations caused by
toxin feeding induce otherwise benign gut bacteria to exert
pathogenic effects.” Futhemore, Boderick et al. (2009)
suggest that the mechanisms found “between B. thur-
ingiensis and the gut microbiota of Lepidoptera may
provide a useful model with which to identify the factors
involved in such transitions.” The authors think that their
findings might be especially helpful in pest management
by increasing susceptibility or preventing resistance.
However, the authors do not consider any implications to
risk assessment in non-target organism, but a detailed
review of other publications reveals that additional factors
are of general relevance of mechanism of Bt toxins. Some
publications indicate that this is also relevant for suscep-
tibility in non-target organisms.
According to Schnepf et al. (1998), there are reasons to
assume that the broad range of naturally occurring toxins in
B. thuringiensis can be explained to some extent by
evolutionary principles, since coexpression of multiple
toxins in general is likely to increase the host range. This
assumption is supported not only by the great variety of
different Bt toxins in bacterial strains but also by at least
some evidence of a synergistic mode of action, as shown in
some publications, revealing synergism (but also surpris-
ingly antagonism) between the toxins as well as between
the toxins and the spore part of the bacteria (Schnepf et al.
1998; Lee et al. 1996; Liu et al. 1998). Sharma et al. (2004)
for example provide an overview of some publications that
deal with the synergism (and sometimes antagonism)
between different Cry1 toxins and between Cry1 and
Cry2 toxins. Liu et al. (1998) show that synergism with
the spore part can help to overcome resistance to the Bt
toxin. Perez et al. (2005) describe synergism between Bt
toxins that can help to replace the function of certain
receptors.
Beyond that, Bt toxins not only show synergism with
one another and the spore part of the bacteria but also with
co-factors in their environment. For example, Sharma et al.
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and proteins from sources other than B. thuringiensis
reveal relevant synergisms with Bt toxins. Dubois and
Dean (1995) prove synergies with several bacteria, some
of them related to infectious diseases. Koppenhöfer and
Kaya (1997) identify interactions with further stress
factors such as nematodes and cadmium in target
organisms. Kramarz et al. (2007) show that additional
factors such as cadmium and nematodes can enable Bt
toxins to have an impact also on organisms such as snails
(Helix aspersa) ,w h i c hd on o ts h o wa n ye f f e c t so nb e i n g
exposed to the Bt toxin alone.
Altogether, several publications are available showing
that the dose–response relationship can depend on syner-
gism, very often resulting in a higher efficacy (toxicity)
(Oppert 1999; Schnepf et al. 1998; Koppenhöfer and Kaya
1997; Kramarz et al. 2007; Sharma et al. 2004). Further-
more, in some cases, tendencies toward a change in
specifity can be observed, leading to a lower selectivity
(Schnepf et al. 1998; Kumar and Venkateswerlu 1998;
Perez et al. 2005; Kramarz et al. 2007). These findings
make it evident that the observed effects are relevant not
only for target organisms but also for non-target organisms
and therefore should be reflected in ecological risk
assessment of Bt toxins. Selected publications with
relevance for Cry1A toxins and potential factors enhanc-
ing toxicity are listed in Table 1. This table shows not only
few effects in non-target organism being found in this
context, but it also shows that hardly any research was
considered or performed on this specific topic. Figure 1
shows the steps necessary to activate Cry 1Ab and lists
some factors that can have an impact on this process.
4 Discussion
Current genetic engineering in plants uses specific com-
pounds derived from B. thuringiensis, which are supposed
to have a high selectivity for some pest insects. For
example, a modified Cry1Ab is used quite frequently in
crops such as maize MON810, Bt 11, and Bt 176. In some
cases, the Bt toxins even get combined in the so-called
stacked events containing more than one Bt toxin (see for
example EFSA 2005). Risk assessment of Bt crops is
largely based on the selectivity of the toxins used and the
assumption of a linear dose–response relationship
(Monsanto 2007). This approach seems to be too narrow,
since, for example, the publications mentioned above show
that the efficacy of Cry1Ab can depend on additional
factors (Dubois and Dean 1995; Schnepf et al. 1998;
Sharma et al. 2004; Broderick et al. 2006; Li et al. 2007;
Kramarz et al. 2007). As to the selectivity of Cry1Ab and
the question if it can be lowered by synergistic action, so
far, no systematic research has been published, but there are
some relevant scientific findings in non-target organisms
supporting this thesis (Kaatz 2005; Kramarz et al. 2007).
The investigation of Kaatz (2005), which so far is not
available in peer reviewed publication, shows some
interesting parallels with Broderick et al. (2006, 2009) and
Dubois and Dean (1995): Honeybee colonies were found to
be susceptible to Cry1Ab if certain parasitic gut organism
(Nosema apis) were apparent. Thus, this organism might
act an additional stress factor, which enables some toxicity
of Cry1Ab in this specific non-target species. Even some
experts who are convinced that there is but few evidence
for the impact of Bt toxins on non-target organisms (and
Table 1 Examples for published research on factors influencing toxicity of Cry1A toxins







Bravo et al. (2004) Oligomerization by enzymes + ? No
Broderick et al. (2006, 2009) Microorganism in the gut + ? No
Dubois and Dean (1995) Diverse bacteria + ? No
Bacterial spores
Gomez et al. (2002) Oligomerization by antibodies and enzymes + ? No
Huang et al. (2002) Activation of toxin by gene transfer to plants + ? No
Kaatz (2005) Nosema apis (in honey bees) + + Yes
Kramarz et al. (2007) Cadmium and nematodes (in snails) + + Yes
Lee et al. (1996) Synergism with other Cry toxins + − ?N o
Li et al. (2007) Activation of toxin by gene transfer to plants + ? No
Soberon et al. (2007) Oligomerization by genetic engineering + ? No
Sharma et al. (2004) Synergism with other Cry toxins + − ?N o
Protease inhibitors
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synergism of Bt toxins with additional stress factors needs
to be investigated further (Duan et al. 2008). This point of
view is also shared by EFSA (2008).
In fact a broad range of publications can be identified,
which deal with effects on non-target organism, but hardly,
any explanatory mechanisms have been described so far.
For example, several publications show effects of Cry1Ab
on insects not belonging to the group of Lepidoptera.
Effects are described for Adalia bipunctata (Schmidt et al.
2008), Chrysoperla carnea (Hilbeck et al. 1998, 1999),
Daphnia magna (Bøhn et al. 2008), Trichopteran,
(Lepidostoma liba, Rosi-Marshall et al. 2007), honeybees
(Apis mellifera, Ramirez-Romero et al. 2008), and others
(see for example Lövei and Arpaia 2005).
Looking beyond insects, too, however, there are effects
of Bt toxins that are difficult to explain by generally
assumed receptor theories. According to Griffitts et al.
(2005), only non-vertebrates can be seen as potential target
organisms for Bt endotoxins. However, Huffmann et al.
(2004) raise questions beyond receptor-specific activity of
Bt toxins also being relevant for vertebrates. In addition, Ito
et al. (2004) show cytocidal activity on human cells. Taking
into accord the question of certain factors influencing the
toxicity of Bt toxins in non-target organism such as
mammals, it is interesting that Thomas and Ellar (1983)
show that the effect of certain Bt toxins (from B.
thuringiensis var. israelensis), which, in their native
(crystallized) form, show no toxicity in mammalians, can
become highly toxic in an alkali-solubilized form (if being
administered parenteral).
There are several reasons for exploring this issue further
especially in the context of genetically engineered plants.
Compared to the naturally occurring (non-active) pro-toxin,
the Bt toxin, as expressed in genetically engineered plants,
not only has a different structure (Hilbeck and Schmidt
2006) but also has, partially, a changed quality in its mode
of action. In addition, plant enzymes can help to activate
(solubilize) the Bt toxin in MON810 (Li et al. 2007), so the
resistance to native Bt toxins acquired in pest insects does
not necessarily work on genetically engineered plants
(Huang et al. 2002; Li et al. 2007). This finding is relevant
for the issue of selectivity, since activation (solubilizing)
normally requires certain conditions to be met in the gut of
insects (de Maagd et al. 2001). As mentioned, Thomas and
Ellar (1983) show that this step of activation can be
decisive for toxicity of some Bt toxins (derived from B.
thuringiensis var israelensis) on mammalian cells.
Also of relevance is the fact that the Bt toxin integrated
into the genetically engineered plants is available through-
out the whole season, and its concentration shows a broad
range of variations (Nguyen and Jehle 2007; Then and
Lorch 2008). This permanent exposure with varying
Fig. 1 Steps of activation of Cry toxins and some mechanisms
contributing to its selectivity. a The crystal form of the protoxin is
produced by Bacillus thuringiensis. It is transformed in the gut of the
insect larvae to a solubilized active toxin, which is shorter than the
protoxin and consists of three domains. An alkaline pH and certain
enzymes are needed for this process of activation (Oppert 1999).
These steps are not necessary for Cry toxins produced in genetically
engineered plants, which are activated by the technical process and by
plant enzymes (Hilbeck and Schmidt 2006; Li et al. 2007). b There is
currently discussion on the relationships between several types of
midgut receptors and the binding of the toxins, while some experts
question the role of receptors in general (Crickmore 2005; Pigott and
Ellar 2007). It is shown that some specific cofactors can synergize
with the Cry toxins at this step (Perez et al. 2005; Soberon et al.
2007). It is not clear which role exactly extrinsic (stress) factors can
play in this context. Synergies are observed by, for example, Dubois
and Dean (1995), Kaatz (2005), and Kramarz et al. (2007), and several
effects are reported on non-target organisms indicating need for
further investigation. c Several mechanisms are discussed for the last
step of toxin reaction: Models exist with and without pores in the
epithelial cell layer and with and without involving gut bacteria
(Broderick et al. 2006; Pigott and Ellar 2007)
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interactions with external factors.
5 Conclusions
In general, the mode of action of some Bt toxins might
have been described well enough to explain how they
work in target organisms. However, open questions still
need to be answered, especially to which extent the
selectivity and dose–response relationship of Bt toxins
are influenced by synergism with certain extrinsic factors
and if these effects could enable toxicity in non-target
organisms. This review sees a risk assessment based only
on the general assumption of high selectivity and a linear
dose–response relationship as lacking a sufficient scien-
tific basis. Thus, the issue of synergism, efficacy, and
selectivity is a quite relevant topic for risk assessment of
genetically engineered Bt crops.
6 Recommendations and perspectives
So far, there are no systematic (published) investigations
related to risk assessment and synergism, selectivity, and
efficacy of the Bt toxin in the context of risk assessment of
genetically engineered crops. Most of the publications
cited deal with emerging resistances in target organism
and leave aside the issue of risk assessment in non-target
organisms. There are several possibilities for further
systemic investigation of impact of additional factors on
the efficacy and selectivity of toxins that might be applied
on Bt toxins, such as tests developed by Broderick et al.
(2009) using the application of certain gut bacteria.
Another test might be developed on the results of Kramarz
et al. (2007), which studied the synergistic effects of
abiotic and biotic stress factors on snails. Relevant models
are also developed by pharmaceutical research (see for
example Fang et al. 2008). Similar tests should be
integrated in current risk assessment, also endorsing test
systems such as mammalian cells, becoming a prerequisite
for any market authorisation.
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